echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Ann Rheu Dis: Scientists identified potential targets for the development of the COVID-19 vaccine!

    Ann Rheu Dis: Scientists identified potential targets for the development of the COVID-19 vaccine!

    • Last Update: 2020-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    , June 5, 2020 /PRNewswire
    /-- In a recent study published in the international journal
    annals of the Rheumatic Diseases, scientists from the University of Manchester and other institutions found that special parts of SARS-CoV-2 may activate host immune responses, so they could be a potential target for late scientists to develop new vaccinesPicture Source: NIAID
    In the article, the researchers used new technology to analyze the overall immune response of patients with dermatitis and identified a link between lifetime exposure to coronavirus infections; iexclusiveinflammatory myopathy, a type of disease characterized by skeletal muscle inflammation, the main disease site of
    inflammation of the lungs, heart
    and skin;researchers used a new method to identify antibodies produced by the immune system's resistance to multiple types of infections, which are on average higher in patients with dermatitis than healthy individuals;three specific parts of the bat coronavirus protein that stimulate the host body's immune response are highly similar to those of human SARS-CoV-2 that induce COVID-19; researcher Janine Lamb said a comparative study of 20 dermatitis and 20 healthy individuals could reveal the host body's immune response to coronavirus infection, while also identifying new targets for developing COVID-19 vaccinesif patients with muscle inflammation who carry antibodies against TRIM33 cannot regulate
    the function of the autoimmunesystem, they will not be able to effectively limit
    microbial infections;concluding researcher Professor Ian Hampson said: 'This study provides a good example of the application of our new serum antibody analysis (SARA) technique, which can be used to track the self-proteins of microbes and antibodies targeting, but it is clear that binding antibodies to these proteins is missing later in the study( original origins: Spyridon Megremis, Thomas D J Walker, Xiaotong He, et al.
    Antibodies agains deveri-beta-theos with high-sequence identity to SARS-CoV-2 in patients with autoimmune dematomyositis , Annals of the Rheumatic Disease
    (2020) doi: 10.1136/annheumdis-2020-2175
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.